Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CorMedix Therapeutics
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age 18 or older
2. eGFR between 15 ml/min/1.73 m2 and \< 60 ml/min/1.73 m2
3. Presence of at least one additional risk factor:
* Diabetes Mellitus type 1 or 2
* Age ≥ 75 years
* Left Ventricular Ejection Fraction ≤ 40%
You may not be if
1. End-Stage Renal Disease
2. Primary PCI for STEMI
3. Currently receiving mechanical ventilation
4. Known active liver disease or liver failure
5. Evidence of hemodynamic instability, such as a requirement for pressor agents
6. Exposure to contrast media within prior 10 days
7. Currently receiving fenoldopam, dopamine, theophylline, aminophylline, mannitol, or Ascorbic acid (\> 2 g/day)
8. Absolute neutrophil count \< 1500
Clareo Health | Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
